What is Catalyst OrthoScience?
Founded in 2014 by orthopedic surgeon Dr. Steven Goldberg and headquartered in Naples, Florida, Catalyst OrthoScience is dedicated to redefining shoulder replacement surgery through less invasive techniques. The company's total shoulder systems are engineered for precision, aiming to preserve bone and soft tissue while ensuring consistent, reproducible outcomes. This approach differentiates Catalyst OrthoScience from traditional methods, promising a more natural-feeling shoulder for patients. With a robust portfolio of patents, the company's technology is currently available across the United States, positioning it as a key innovator in the orthopedic sector.
How much funding has Catalyst OrthoScience raised?
Catalyst OrthoScience has raised a total of $40.2M across 5 funding rounds:
Debt
$350K
Debt
$713K
Other Financing Round
$20M
Private Equity
$4.1M
Debt
$15M
Debt (2020): $350K with participation from PPP
Debt (2021): $713K led by PPP
Other Financing Round (2024): $20M supported by RC Capital, Mutual Capital Partners, and Bridge Bank
Private Equity (2025): $4.1M, investors not publicly disclosed
Debt (2025): $15M backed by RC Capital, Mutual Capital Partners, and Western Alliance Bank
Key Investors in Catalyst OrthoScience
RC Capital
RC Capital is a growth equity firm focused on building high-potential healthcare companies by leveraging the interplay of medical devices, healthcare services, and healthcare IT. The firm is dedicated to investing in companies that enhance patient outcomes and improve the delivery of care.
Mutual Capital Partners
Mutual Capital Partners is a Cleveland-based venture capital fund that focuses on investing in early-stage software and medical device companies in the Midwest. The firm partners with innovative healthcare startups, providing not just financial support but also guidance and resources to help them succeed.
Western Alliance Bank
Western Alliance Bancorporation is a bank holding company that engages in the provision of deposit, lending, treasury management, international banking, and online banking products and services for businesses. It operates through various business segments including Technology and Innovation.
What's next for Catalyst OrthoScience?
The recent major strategic investment in Catalyst OrthoScience signals a pivotal growth phase for the company. This capital infusion is expected to accelerate the expansion of its innovative shoulder replacement technologies and potentially broaden its market reach. The company's focus on less invasive surgical techniques aligns with the growing demand for patient-centric healthcare solutions, suggesting a strong trajectory for future development and commercialization. Further strategic partnerships or funding rounds may be anticipated as Catalyst OrthoScience continues to scale its operations and enhance its product offerings in the competitive orthopedic market.
See full Catalyst OrthoScience company page
